$IMMP
Immutep Limited
PRICE
$2.16 -
Delayed Price
VOLUME
13,609
DAY RANGE
-
52 WEEK
1.85 - 5
Key Metrics
Market Cap
187.11 M
Beta
1.54
Avg. Volume
110.80 K
Shares Outstanding
86.62 M
Yield
0%
Public Float
0
Next Earnings Date
2022-08-30
Next Dividend Date
Company Information
Immutep is a globally active biotechnology company that is a leader in the development of LAG-3 related immunotherapeutic products for the treatment of cancer and autoimmune disease. Immutep is dedicated to leveraging its technology and expertise to bring innovative treatment options to market for patients and to maximize value to shareholders.
CEO: Marc Voigt
Website: www.immutep.com
HQ: Plaza Building Sydney, 2000 New South Wales
Related News